SEC Form 4 · accession 0001093557-17-000076

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CTO

Period of report

Mar 10, 2017

Accepted (ET)

Mar 14, 2017 · 7:59 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001093557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Mar 10, 2017	J	11,834	$78.24	D	60,500	D
Common Stock^F1,F2	Mar 10, 2017	J	7,500	$78.24	D	53,000	D
Common Stock^F1,F2	Mar 10, 2017	J	12,667	$78.24	D	40,333	D
Common Stock^F3,F4	Mar 10, 2017	D	6,254	$77.5506	D	34,079	D
Common Stock^F1,F4,F5	Mar 10, 2017	J	11,834	$78.24	A	15,333	I	by Trust
Common Stock^F1,F4,F5	Mar 10, 2017	J	7,500	$78.24	A	22,833	I	by Trust
Common Stock^F1,F4,F5	Mar 10, 2017	J	12,667	$78.24	A	35,500	I	by Trust
Common Stock^F3,F4,F5	Mar 10, 2017	D	6,694	$77.5506	D	28,806	I	by Trust
Common Stock^F3,F4,F5	Mar 10, 2017	D	3,964	$77.5506	D	24,842	I	by Trust
Common Stock^F6,F7,F4,F5	Mar 13, 2017	S	14,400	$77.744	D	10,442	I	by Trust

No Table II lines on this filing.

F1Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units.
F2Included in this number are 40,333 unvested restricted stock units, 25,333 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 15,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018.
F3These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
F4Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011.
F5Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.
F6On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F7This transaction was executed in multiple trades at prices ranging from $77.41 to $78.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.